India, April 23 -- Speciality Medicines Limited has entered into a commercial agreement with an overseas company engaged in the import and distribution of pharmaceutical finished products, marking a step forward in its growth strategy.
Under the arrangement, the international partner will distribute, market, and sell the company's products, with the deal valued at approximately USD 2 million (around ?18.8 crore), subject to mutually agreed terms and conditions.
The order has been secured from an international entity and is expected to strengthen the company's distribution reach and boost its revenue prospects.
The company also clarified that none of its promoters, promoter group, or group entities have any interest in this contract, and ...